17.07.2023 15:00:02
|
EQS-CMS: Siemens Healthineers AG: Release of a capital market information
EQS Post-admission Duties announcement: Siemens Healthineers AG
/ Disclosure pursuant to Art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) No. 596/2014 (MAR) in conjunction with Art. 2 para. 2, para. 3 of the Delegated Regulation (EU) No. 2016/1052 Share buyback 16th Interim and Final Reporting
Disclosure pursuant to Art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) No. 596/2014 (MAR) in conjunction with Art. 2 para. 2, para. 3 of the Delegated Regulation (EU) No. 2016/1052 Share buyback 16th Interim and Final Reporting In the time period from and including 10 July 2023 until and including 13 July 2023, a number of 353,636 shares of Siemens Healthineers AG were bought back within the framework of the share buyback of Siemens Healthineers AG; on 27 March 2023, Siemens Healthineers AG disclosed pursuant to Art. 5 para. 1 lit. a) of the Regulation (EU) No. 596/2014 (MAR) in conjunction with Art. 2 para. 1 of the Delegated Regulation (EU) No. 2016/1052 the start of the share buyback on 29 March 2023 which was completed on 13 July 2023. Shares were bought back as follows:
The transactions are published in a detailed form on the website of Siemens Healthineers AG (https://www.siemens-healthineers.com/investor-relations/share). With these transactions, the share buyback was completed on 13 July 2023.The total volume of shares which were bought back within the framework of the share buyback in the time period from and including 29 March 2023 until and including 13 July 2023 amounts to 7,637,341 shares. This corresponds to approx. 0.68% of the share capital of Siemens Healthineers AG. The average purchase price paid at the stock exchange was EUR 52.37421 per share; the total consideration that was paid for the treasury shares amounts to EUR 399,999,998.60 (in each case excluding incidental transaction charges). The purchase of the shares of Siemens Healthineers AG was carried out by a credit institution that has been commissioned by Siemens Healthineers AG; the shares were repurchased exclusively on the electronic trading platform of the Frankfurt Stock Exchange (XETRA).
Munich, 17 July 2023 Siemens Healthineers AG The Managing Board ______________________________ 1Excluding incidental acquisition costs, rounded to four decimal places according to commercial practice.
17.07.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Siemens Healthineers AG |
Henkestr. 127 | |
91052 Erlangen | |
Germany | |
Internet: | https://www.siemens-healthineers.com |
End of News | EQS News Service |
|
1681569 17.07.2023 CET/CEST
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Siemens Healthineers AGmehr Nachrichten
21.11.24 |
Handel in Frankfurt: LUS-DAX liegt schlussendlich im Plus (finanzen.at) | |
21.11.24 |
Pluszeichen in Frankfurt: DAX schlussendlich fester (finanzen.at) | |
21.11.24 |
Barclays Capital bescheinigt Overweight für Siemens Healthineers-Aktie (finanzen.at) | |
21.11.24 |
DAX 40-Titel Siemens Healthineers-Aktie: So viel Verlust hätte ein Siemens Healthineers-Investment von vor einem Jahr eingebracht (finanzen.at) | |
20.11.24 |
Mittwochshandel in Frankfurt: LUS-DAX schlussendlich in der Gewinnzone (finanzen.at) | |
20.11.24 |
Verluste in Frankfurt: DAX beendet die Mittwochssitzung mit Verlusten (finanzen.at) | |
20.11.24 |
Schwacher Handel in Frankfurt: LUS-DAX sackt nachmittags ab (finanzen.at) | |
20.11.24 |
XETRA-Handel DAX notiert am Nachmittag im Minus (finanzen.at) |
Analysen zu Siemens Healthineers AGmehr Analysen
21.11.24 | Siemens Healthineers Overweight | Barclays Capital | |
21.11.24 | Siemens Healthineers Buy | Jefferies & Company Inc. | |
15.11.24 | Siemens Healthineers Overweight | JP Morgan Chase & Co. | |
12.11.24 | Siemens Healthineers Neutral | UBS AG | |
11.11.24 | Siemens Healthineers Halten | DZ BANK |